Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
- Products
-
- Cinacalcet Hydrochloride Tablets 60 mg
- Company
- Slate Run Pharmaceuticals
- Where it was sold
-
Product was distributed to 8 distributors who may have further distribute the product nationwide.
Nationwide
- Units affected
- 2,444 bottles
- About this recall
- Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04